NCT00898677View on ClinicalTrials.gov

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,268

Participants

Timeline

Start Date

September 30, 1995

Primary Completion Date

May 31, 1996

Study Completion Date

September 30, 1996

Conditions
Migraine Headache
Interventions
DRUG

rizatriptan benzoate

single dose administration of 5mg rizatriptan (by Mouth) p.o.

DRUG

rizatriptan benzoate

single dose administration of 10 mg rizatriptan p.o.

DRUG

Comparator: sumatriptan

single dose administration of sumatriptan 100 p.o.

DRUG

Comparator: Placebo

placebo to rizatriptan

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00898677 - Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) | Biotech Hunter | Biotech Hunter